Skip to main content
OpenTrials
Completed

NCT Number: NCT06710041

Kinesiotaping in Carpal Tunnel Syndrome

Objective: Kinesiotaping (KT) is a relatively new technique, which reduces the pressure on the median nerve by extending the transverse carpal ligament. The aim of this study was to evaluate the effectiveness of KT on Carpal tunnel syndrome (CTS) in a randomized, placebo-controlled manner.

Methods: Patients were randomly divided into three groups: Group 1 (KT plus tendon and nerve gliding exercises), Group 2 (sham-taping plus exercises) and Group 3 (exercises alone, control group). KT was applied 3 times with 5-day intervals throughout the study, with "neural technique" for median and ulnar nerves and "area correction technique" for carpal tunnel releasing. In the placebo group kinesiotapes were applied without stretching and proper position. Hand grip strength, VAS, Boston Carpal Tunnel Syndrome Questionnaire (BCTQ), and Short Form-12 (SF-12) were measured as outcome parameters at the first visit, 3rd and 6th week.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Karadeniz Technical University

Trabzon, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • clicical diagnosis of mild and moderate CTS
  • having the CTS symptoms for at least 6 weeks

Exclusion criteria

  • electrophysiological diagnosis of severe CTS,
  • thenar atrophy,
  • local corticosteroid injection or KT application or physical therapy treatment for CTS within the last 3 months,
  • patients with secondary metabolic causes for CTS (such as diabetes mellitus, pregnancy, rheumatoid arthritis, sarcoidosis, thyroid disease),
  • patients with other conditions that may cause neck and arm pain (cervical disc hernia, arthritis, epicondylitis, rotator cuff syndrome),
  • a history of fracture in the wrist,
  • previous CTS surgery.

Treatment and study plan

kinesiotape

Device

Kinesiotape, when applied with a specific method and tension, significantly reduces the pressure on the median nerve by extending the transverse carpal ligament. It regulates edema under the skin and improves lymphatic and blood circulation. It reduces muscle spasms, eases the movement of tendons and fascia, and reduces pain through neurological suppression

Exercise

Other

Tendon and nerve gliding exercise

Sham Taping

Device

In the sham taping group, kinesiotape was applied with two I bands without stretching and without having the proper position. This group was considered as the placebo group.

Primary outcomes

  1. pain level

    Time frame: From enrollment to the end of treatment at 3 weeks

    pain level was assessed using visual analog scale.The minimum and maximum values were 0 and 10, and higher scores mean a better outcome.

Secondary outcomes

  1. Boston Carpal Tunnel Syndrome Questionnaire (BCTQ)

    Time frame: From enrollment to the end of treatment at 6 weeks

    The BCTQ is a disease specific questionnaire to evaluate the symptom severity and functional capacity. High scores indicate increased symtom severity and low functional capacity

Sponsors and collaborators

Lead sponsor

Karadeniz Technical University

Other

Registry information

Official study title

Effects of Kinesiotaping in Carpal Tunnel Syndrome Treatment: a Randomized Controlled Trial

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Nov 29, 2024
Registry last updated
Nov 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.